These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31122805)

  • 21. Dysfunctional astrocytes as key players in the pathogenesis of central nervous system disorders.
    De Keyser J; Mostert JP; Koch MW
    J Neurol Sci; 2008 Apr; 267(1-2):3-16. PubMed ID: 17935736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Roles of AEG-1 in CNS neurons and astrocytes during noncancerous processes.
    Yin X; Feng H
    J Neurosci Res; 2017 Oct; 95(10):2086-2090. PubMed ID: 28370184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Astrocyte-neuron metabolic relationships: for better and for worse.
    Allaman I; Bélanger M; Magistretti PJ
    Trends Neurosci; 2011 Feb; 34(2):76-87. PubMed ID: 21236501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Astrocytes Pathology in ALS: A Potential Therapeutic Target?
    Johann S
    Curr Pharm Des; 2017; 23(33):5022-5036. PubMed ID: 28619000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histamine and astrocyte function.
    Jurič DM; Kržan M; Lipnik-Stangelj M
    Pharmacol Res; 2016 Sep; 111():774-783. PubMed ID: 27475882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Switching from astrocytic neuroprotection to neurodegeneration by cytokine stimulation.
    Efremova L; Chovancova P; Adam M; Gutbier S; Schildknecht S; Leist M
    Arch Toxicol; 2017 Jan; 91(1):231-246. PubMed ID: 27052459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovering novel phenotype-selective neurotrophic factors to treat neurodegenerative diseases.
    Petrova PS; Raibekas A; Pevsner J; Vigo N; Anafi M; Moore MK; Peaire A; Shridhar V; Smith DI; Kelly J; Durocher Y; Commissiong JW
    Prog Brain Res; 2004; 146():168-83. PubMed ID: 14699964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular diversity of astrocytes with implications for neurological disorders.
    Bachoo RM; Kim RS; Ligon KL; Maher EA; Brennan C; Billings N; Chan S; Li C; Rowitch DH; Wong WH; DePinho RA
    Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8384-9. PubMed ID: 15155908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Astrocytes: Heterogeneous and Dynamic Phenotypes in Neurodegeneration and Innate Immunity.
    Cunningham C; Dunne A; Lopez-Rodriguez AB
    Neuroscientist; 2019 Oct; 25(5):455-474. PubMed ID: 30451065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and characterization of uptake systems for cystine and cysteine in cultured astrocytes and neurons: evidence for methylmercury-targeted disruption of astrocyte transport.
    Shanker G; Aschner M
    J Neurosci Res; 2001 Dec; 66(5):998-1002. PubMed ID: 11746429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amyloid-beta aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability.
    Allaman I; Gavillet M; Bélanger M; Laroche T; Viertl D; Lashuel HA; Magistretti PJ
    J Neurosci; 2010 Mar; 30(9):3326-38. PubMed ID: 20203192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting Astrocytes for Treating Neurological Disorders: Carbon Monoxide and Noradrenaline-Induced Increase in Lactate.
    Horvat A; Vardjan N; Zorec R
    Curr Pharm Des; 2017; 23(33):4969-4978. PubMed ID: 28641546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Friends Turn Foe-Astrocytes Contribute to Neuronal Damage in NeuroAIDS.
    Pandey HS; Seth P
    J Mol Neurosci; 2019 Oct; 69(2):286-297. PubMed ID: 31236774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monocyte chemoattractant protein-1 and macrophage inflammatory protein-2 are involved in both excitotoxin-induced neurodegeneration and regeneration.
    Kalehua AN; Nagel JE; Whelchel LM; Gides JJ; Pyle RS; Smith RJ; Kusiak JW; Taub DD
    Exp Cell Res; 2004 Jul; 297(1):197-211. PubMed ID: 15194436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Astrocyte support is important for the compensatory potential of the nigrostriatal system neurons during early neurodegeneration.
    Kuter K; Olech Ł; Głowacka U; Paleczna M
    J Neurochem; 2019 Jan; 148(1):63-79. PubMed ID: 30295916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Approaches of the Transcriptomic Analysis in Astrocytes: Potential Pharmacological Targets.
    Barreto GE; Gomez RM; Bustos RH; Forero DA; Aliev G; Tarasov VV; Yarla NS; Echeverria V; Gonzalez J
    Curr Pharm Des; 2017; 23(28):4189-4197. PubMed ID: 28393699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Region-Restrict Astrocytes Exhibit Heterogeneous Susceptibility to Neuronal Reprogramming.
    Hu X; Qin S; Huang X; Yuan Y; Tan Z; Gu Y; Cheng X; Wang D; Lian XF; He C; Su Z
    Stem Cell Reports; 2019 Feb; 12(2):290-304. PubMed ID: 30713039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dual face of connexin-based astroglial Ca(2+) communication: a key player in brain physiology and a prime target in pathology.
    De Bock M; Decrock E; Wang N; Bol M; Vinken M; Bultynck G; Leybaert L
    Biochim Biophys Acta; 2014 Oct; 1843(10):2211-32. PubMed ID: 24768716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reconstitution of human immunodeficiency virus-induced neurodegeneration using isolated populations of human neurons, astrocytes, and microglia and neuroprotection mediated by insulin-like growth factors.
    Wang J; Gabuzda D
    J Neurovirol; 2006 Dec; 12(6):472-91. PubMed ID: 17162663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic gene expression changes in astrocytes in Multiple Sclerosis cerebral cortex are indicative of immune-mediated signaling.
    Zeis T; Allaman I; Gentner M; Schroder K; Tschopp J; Magistretti PJ; Schaeren-Wiemers N
    Brain Behav Immun; 2015 Aug; 48():313-25. PubMed ID: 25937052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.